May 22, 2017 09:56 AM EDT

Ablynx grabs a €15M milestones payment from Merck KGaA; EyeGate surges on Valeant payout

John Carroll

Editor & Founder

→ Belgium’s Ablynx has teed up one of its Nanobodies for osteoarthritis for Merck KGaA. The German company accepted it and will now take …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Ablynx grabs a €15M milestones payment from Merck KGaA; EyeGate surges on Valeant payout

John Carroll

Editor & Founder

Sign up to read this article for free.

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA

Pharma's wins and losses in Trump's sprawling executive order on drug prices

Eli Lilly reports first Phase 3 data for oral GLP-1, posting a win in diabetes

Sarepta loses CMO to RNA editing upstart; Another wave of personnel moves at Dyne

Sanofi to pay $125M upfront for two immunology drugs from little-known biotech

US drugs rely heavily on ingredients made overseas, new report shows

New York-based partnership sets the standard for expanding clinical trial access for underserved and diverse ...

Abl­ynx grabs a €15M mile­stones pay­ment from Mer­ck KGaA; Eye­Gate surges on Valeant pay­out

Editor & Founder

Sign up to read this article for free.

Autonomy Bio Inc.

San Francisco, CA 94107, USA

Ablynx grabs a €15M milestones payment from Merck KGaA; EyeGate surges on Valeant payout